Year None202620252024202320222021202020192018 Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jun 04, 2026 Read More Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update May 15, 2026 Read More Sensei Biotherapeutics Doses First Patient in Phase 1b/2 Trial of PIKTOR in HR+/HER2- Advanced Breast Cancer May 05, 2026 Read More Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference Apr 09, 2026 Read More Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update Mar 30, 2026 Read More Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Mar 17, 2026 Read More Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Feb 25, 2026 Read More Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement Feb 18, 2026 Read More
